Elinogrel, an orally and intravenously available ADP-receptor antagonist. How does elinogrel affect a personalized antiplatelet therapy? [electronic resource]
Producer: 20130115Description: 191-4 p. digitalISSN:- 2567-5761
- Administration, Oral
- Evidence-Based Medicine
- Fibrinolytic Agents -- administration & dosage
- Humans
- Injections, Intravenous
- Platelet Aggregation Inhibitors -- administration & dosage
- Precision Medicine -- methods
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Quinazolinones -- administration & dosage
- Sulfonamides -- administration & dosage
- Thrombosis -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.